Related Experiment Videos
Telangiectasia macularis eruptiva perstans
1Ronald O. Perelman Department of Dermatology, New York University, USA.
Dermatology Online Journal
|March 8, 2005
Summary
Telangiectasia macularis eruptiva perstans (TMEP) is a rare skin condition. This case report highlights potential treatment options for TMEP, including laser therapy and radiation.
Area of Science:
- Dermatology
- Oncology
Background:
- Mastocytosis is a group of disorders characterized by an abnormal proliferation of mast cells.
- Telangiectasia macularis eruptiva perstans (TMEP) is a rare cutaneous variant of mastocytosis.
Observation:
- A 45-year-old male presented with skin lesions consistent with TMEP.
- The patient's condition was diagnosed through clinical and histological examination.
Findings:
- TMEP is primarily a skin-localized condition, but systemic involvement can occur.
- Mutations in the c-kit proto-oncogene are implicated in mast cell hyperplasia in some mastocytosis cases.
Implications:
- Treatment strategies for TMEP are guided by the presence of systemic disease or symptoms.
- Case reports suggest potential therapeutic benefits from 585-flashlamp pumped dye lasers and electron beam radiation for TMEP.